Letter from Dr R S Lane to Dr B Davis. The letter summarises the issues around a trial of Octaplas to assess its safety and efficacy. The key issues focus on the risk of transmission of hepatitis A by high purity factor VIII and blood and blood products from single donor and pooled plasma.